alatrofloxacin alatrofloxacin alatrofloxacin (trovan iv) is a fluoroquinolone antibiotic developed by pfizer, delivered as a mesylate salt. alatrofloxacinclinical dataahfs/drugs.commicromedex detailed consumer informationmedlineplusa605016routes ofadministrationintravenousatc codenonelegal statuslegal status withdrawn pharmacokinetic databioavailabilityn/aprotein binding76% (trovafloxacin)metabolismquickly hydrolyzed to trovafloxacinelimination half-life9 to 12 hours (trovafloxacin)excretionfecal and renal (trovafloxacin)identifiers iupac name 7-amino}-1-oxopropan-2-yl]amino}-3-azabicyclohexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid cas number146961-76-4 nchemspider21243647 nunii7qvv6i50dtchemblchembl1201197 nchemical and physical dataformulac26h25f3n6o5molar mass558.518 g·mol−13d model (jsmol)interactive image smiles c(c(=o)n(c)c(=o)n121cn(c2)c3=c(c=c4c(=o)c(=cn(c4=n3)c5=c(c=c(c=c5)f)f)c(=o)o)f)n inchi inchi=1s/c26h25f3n6o5/c1-10(30)24(37)31-11(2)25(38)32-20-14-7-34(8-15(14)20)23-18(29)6-13-21(36)16(26(39)40)9-35(22(13)33-23)19-4-3-12(27)5-17(19)28/h3-6,9-11,14-15,20h,7-8,30h2,1-2h3,(h,31,37)(h,32,38)(h,39,40)/t10-,11-,14-,15+,20+/m0/s1 nkey:uuzppamzdfluhd-vujlhgsvsa-n n ny (what is this?) (verify) trovafloxacin and alatrofloxacin were both withdrawn from the u.s. market in june 2006 due to hepatotoxicity leading to liver transplant or death.